Torsin-1A-interacting Protein 1 (ISOform 1) as A Drug Target and Biomarker

Target Name: TOR1AIP1

NCBI ID: G26092

TOR1AIP1

Torsin-1A-interacting Protein 1 (ISOform 1) as A Drug Target and Biomarker

Torsin-1A-interacting protein 1 (ISOform 1) is a protein that is expressed in various tissues and cells in the human body. It plays a critical role in the regulation of cell signaling pathways, and is involved in the development and maintenance of tissues and organs.

Recent studies have identified TOR1AIP1 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its functions and interactions with other proteins have also been the subject of intense research, providing new insights into its role in these fields.

Torsin-1A-interacting protein 1 (ISOform 1) is a member of the TOR signaling pathway, which is a well-established network of protein interactions that regulates cellular signaling pathways. The TOR signaling pathway is involved in various cellular processes, including cell growth, differentiation, metabolism, and stress response.

The TOR signaling pathway is composed of several key components, including the protein TOR, which is the central protein of the pathway, and various interacting proteins. These interacting proteins can either activate or inhibit the activity of TOR, leading to changes in cellular behavior.

Torsin-1A-interacting protein 1 (ISOform 1) is one of the interacting proteins that can modulate the activity of TOR. It is expressed in various tissues and cells, including the brain, heart, and kidneys, and has been shown to play a role in the regulation of neurotransmitter signaling pathways.

In neurotransmission, Torsin-1A-interacting protein 1 (ISOform 1) is involved in the regulation of the release and uptake of neurotransmitters, such as dopamine, serotonin, and endocannabinoids. It has been shown to interact with the neurotransmitter receptor PSD9, which is involved in the regulation of neurotransmitter signaling pathways.

Torsin-1A-interacting protein 1 (ISOform 1) has also been shown to play a role in the regulation of cellular stress responses. It has been shown to interact with the protein p62, which is involved in the regulation of cellular stress responses.

In autoimmune diseases, Torsin-1A-interacting protein 1 (ISOform 1) has been shown to play a role in the regulation of immune cell function. It has been shown to interact with the immune checkpoint protein PD-1, which is involved in the regulation of immune cell proliferation and survival.

In cancer, Torsin-1A-interacting protein 1 (ISOform 1) has been shown to play a role in the regulation of cell signaling pathways that promote tumor growth and metastasis. It has been shown to interact with the oncogene Badp7, which is involved in the regulation of cell signaling pathways that promote tumor growth and metastasis.

Torsin-1A-interacting protein 1 (ISOform 1) is also a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its functions and interactions with other proteins have also been the subject of intense research, providing new insights into its role in these fields.

In conclusion, Torsin-1A-interacting protein 1 (ISOform 1) is a protein that is involved in the regulation of cell signaling pathways and has been identified as a potential drug target and biomarker for various diseases. Its functions and interactions with other proteins have also been the subject of intense research, providing new insights into its role in these fields. Further studies are needed to fully understand its role in the regulation of cellular processes and its potential as a drug target and biomarker.

Protein Name: Torsin 1A Interacting Protein 1

Functions: Required for nuclear membrane integrity. Induces TOR1A and TOR1B ATPase activity and is required for their location on the nuclear membrane. Binds to A- and B-type lamins. Possible role in membrane attachment and assembly of the nuclear lamina

The "TOR1AIP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TOR1AIP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets